Stanniocalcin-1 Protected Astrocytes from Hypoxic Damage Through the AMPK Pathway

Area of Science:

• Neuroscience
• Cell Biology
• Biochemistry

Background:

• Astrocytes exhibit increased stanniocalcin-1 (STC1) expression under hypoxic conditions.
• The precise function of STC1 in hypoxic astrocytes remains largely unelucidated.

Purpose of the Study:

• To investigate the role and regulatory mechanisms of STC1 in astrocytes under hypoxia.
• To elucidate the downstream pathways influenced by STC1 in hypoxic astrocytes.

Main Methods:

• Validation of STC1 expression in astrocyte cell lines and mouse brain tissue under hypoxia.
• Assessment of astrocyte viability, apoptosis, and reactive oxygen species (ROS) levels following STC1 knockdown.
• Analysis of key metabolic and signaling molecules including SIRT3, UCP2, glycolytic genes, AMPKα1, and HIF-1α.

Main Results:

• STC1 expression is upregulated in astrocytes during hypoxia.
• STC1 knockdown impairs astrocyte viability, increases apoptosis, elevates ROS, and reduces levels of SIRT3, UCP2, and glycolytic genes.
• STC1 silencing suppresses glycolysis and promotes oxidative stress by downregulating AMPKα1.
• HIF-1α regulates STC1 and AMPKα1 expression in hypoxic astrocytes.

Conclusions:

• HIF-1α-induced STC1 protects astrocytes from hypoxic injury.
• This protection is mediated through the regulation of glycolysis and redox homeostasis in an AMPKα1-dependent manner.